Roche sales grow ahead of market average
This article was originally published in Clinica
Executive Summary
Roche Diagnostics' sales are growing "substantially faster" than the market average of 4%, with nine-month sales of SFr3.8 billion ($2.5 billion), an 11% increase. The Swiss company continues to reinforce its lead in virtually all businesses and markets, it says.